We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Clarifies Requirements for Impurities, Stability
EMA Clarifies Requirements for Impurities, Stability
April 15, 2010
Drugmakers can use a new European Medicines Agency (EMA) question-and-answer document to help prepare for EU inspections, specifically with regards to
drug impurity levels and stability.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor